Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: a randomized, double-blind, lot-to-lot consistency trial.

Umeh R, Oguche S, Oguonu T, Pitmang S, Shu E, Onyia JT, Daniyam CA, Shwe D, Ahmad A, Jongert E, Catteau G, Lievens M, Ofori-Anyinam O, Leach A.

Vaccine. 2014 Nov 12;32(48):6556-62. doi: 10.1016/j.vaccine.2014.07.067. Epub 2014 Jul 28.

2.

Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.

Tiono AB, Dicko A, Ndububa DA, Agbenyega T, Pitmang S, Awobusuyi J, Pamba A, Duparc S, Goh LE, Harrell E, Carter N, Ward SA, Greenwood B, Winstanley PA.

Am J Trop Med Hyg. 2009 Dec;81(6):969-78. doi: 10.4269/ajtmh.2009.09-0351.

3.

Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.

Ani AE, Idoko J, Dalyop YB, Pitmang SL.

Trans R Soc Trop Med Hyg. 2009 Jan;103(1):67-71. doi: 10.1016/j.trstmh.2008.08.004. Epub 2008 Sep 11.

PMID:
18789463
4.

Comparison of sulfadoxine-pyrimethamine with and without chloroquine for uncomplicated malaria in Nigeria.

Pitmang SL, Thacher TD, Madaki JK, Egah DZ, Fischer PR.

Am J Trop Med Hyg. 2005 Mar;72(3):263-6.

PMID:
15772318

Supplemental Content

Loading ...
Support Center